ketanserin has been researched along with fenoldopam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gretler, DD; Jones, KC; Murphy, MB | 1 |
| Christie, MI; Harper, D; Smith, GW | 1 |
| Stanford, GG | 1 |
1 review(s) available for ketanserin and fenoldopam
| Article | Year |
|---|---|
Use of inotropic agents in critical illness.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Cardiac Output; Cardiotonic Agents; Catecholamines; Critical Care; Dopamine; Fenoldopam; Humans; Imidazoles; Ketanserin; Oxygen; Phosphodiesterase Inhibitors; Quinolines; Vasodilator Agents | 1991 |
2 other study(ies) available for ketanserin and fenoldopam
| Article | Year |
|---|---|
5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Atropine; Benzazepines; Dogs; Dopamine Agents; Drug Interactions; Fenoldopam; In Vitro Techniques; Indomethacin; Ketanserin; Methysergide; Muscle, Smooth; Receptors, Serotonin; Serotonin; Trachea; Vasodilator Agents | 1992 |
Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aorta; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; In Vitro Techniques; Ketanserin; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Vasoconstriction | 1992 |